A rare-disease federal incentive program critical to biotech R&D is in jeopardy, writes Leslie Williams, president and CEO of ...

European equities traded in the US as American depositary receipts were falling on Friday morning, down 1.5% to 1,436.90 on the S&P Europe Select ADR Index. From continental Europe, the gainers were ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

The China fight is on. Last week, the House of Representatives stepped up to the Herculean task of passing 25 bills targeting ...

The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...

Lawmakers took up more than two dozen mostly Republican-led measures aimed at countering Beijing’s technological, political ...

The good news is that if you're willing to put in a bit of effort, it's very possible to improve on your process to secure ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

There are more foreign companies paying to license technology from the U.S. National Institutes of Health than companies ...

This discount is shown at checkout, if applicable. The largest pharmaceutical company in the world has tapped Swiss biotech Haya Therapeutics to develop weight-loss drugs that target a specific ...